Assenagon Asset Management S.A. / PFE
Assenagon Asset Management S.A.’s Pfizer Inc Position
Does Assenagon Asset Management S.A. own Pfizer Inc (PFE)? Yes — 11.90M shares worth $287M (+0.36% of its 13F portfolio) as of Q2 2026, up from 6.07M shares the prior filed quarter.
Position Value
$287M
Q2 2026
Shares
11.90M
% of Portfolio
+0.36%
Quarters Held
29
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 11.90M | $287M | +0.36% |
| Q1 2026 | 6.07M | $171M | +0.26% |
| Q4 2025 | 2.06M | $51M | +0.07% |
| Q3 2025 | 8.69M | $221M | +0.30% |
| Q2 2025 | 4.97M | $120M | +0.18% |
| Q1 2025 | 10.05M | $255M | +0.42% |
| Q4 2024 | 2.47M | $65M | +0.11% |
| Q3 2024 | 5.17M | $150M | +0.28% |
| Q2 2024 | 4.77M | $133M | +0.30% |
| Q1 2024 | 5.97M | $166M | +0.39% |
| Q4 2023 | 6.37M | $183M | +0.49% |
| Q3 2023 | 4.18M | $139M | +0.43% |
| Q2 2023 | 3.07M | $113M | +0.39% |
| Q1 2023 | 6.87M | $280M | +1.00% |
| Q4 2022 | 3.18M | $163,113 | +0.59% |
| Q3 2022 | 12.40M | $543M | +2.08% |
| Q2 2022 | 1.97M | $103M | +0.38% |
| Q1 2022 | 4.60M | $238M | +0.66% |
| Q4 2021 | 3.77M | $222M | +0.64% |
| Q3 2021 | 3.76M | $162M | +0.52% |
| Q2 2021 | 3.29M | $129M | +0.44% |
| Q4 2020 | 933.1K | $34M | +0.15% |
| Q3 2020 | 765.3K | $28M | +0.16% |
| Q2 2020 | 7.1K | $233,000 | 0.00% |
| Q4 2019 | 82.5K | $3M | +0.02% |
| Q3 2019 | 7.5K | $269,000 | 0.00% |
| Q2 2019 | 3.29M | $142M | +1.07% |
| Q1 2019 | 20.0K | $849,000 | +0.01% |
| Q4 2018 | 1.73M | $76M | +0.86% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of PFE.